NEW YORK, Nov. 5 – Incyte Genomics said Monday that it had licensed its main microarray and gene expression patents to Agilent Technologies, a manufacturer of printed DNA microarrays.

Under the terms of the licensing agreements, Incyte will provide Agilent with its patents for nucleic acid linear amplification, the manufacture and use of DNA microarrays, and the use of gene expression arrays in cancer research and diagnosis. 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.